Gosset Handok General Information
Handok has a robust commercial portfolio including both prescription and OTC drugs. It has several approved drugs for diabetes (e.g., Amaryl MEX), oncology (Pemigatinib for cholangiocarcinoma), allergy treatment (Fexofenadine Hydrochloride), hematology/oncology biologics such as Tafasitamab-Cxix for lymphoma. The company also develops medical devices and diagnostics. Recent clinical highlights include positive Phase 2/3 results from its collaborator Compass Therapeutics on Tovecimig for cancer immunotherapy and ongoing late-stage trials with affiliates like Rezolute in rare metabolic diseases[1].
Contact Information
Drug Pipeline
Key Partnerships
Teva Pharmaceutical Industries Ltd. [TEVA-HANDOK JV], Sobi [Sobi-Handok JV], Sanofi/Aventis [historic partnership—Amaryl export/manufacture continues], Compass Therapeutics [cancer immunotherapy collaboration]
Handok Funding
No funding data available